Use of trimetrexate and its salts for the preparation of pharmaceutical compositions for treating infections of the mycobacterium-avium-intracellulare complex
申请人:WARNER-LAMBERT COMPANY
公开号:EP0255100A2
公开(公告)日:1988-02-03
Use of 5-methyl-6-[[(3,4-5-trimethoxyphenyl) amino] methyl]-2,4-quinazolinediamine (trimetrexate) and its pharmaceutically acceptable salts alone or in combination with an inhibitor of folic acid biosynthesis for the preparation of pharmaceutical compositions useful for treating infections of Mycobacterium avium-intracellulare complex in a patient.
5-甲基-6-[[(3,4-5-三甲氧基苯基)氨基]甲基]-2,4-喹唑啉二胺(曲美曲沙)及其药学上可接受的盐类单独使用或与叶酸生物合成抑制剂结合使用,用于制备治疗患者感染分枝杆菌-伞菌复合体的药物组合物。